The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case–control study in Sweden (original) (raw)
Journal Article
,
11
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet
Stockholm, SE 171 77, Sweden
* To whom correspondence should be addressed at: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, SE 171 77, Stockholm, Sweden. Tel: +46 8 52486184; Fax: +46 8 314975; Email: Weimin.Ye@ki.se
Search for other works by this author on:
,
22
Division of Molecular Genetic Epidemiology, German Cancer Research Center
69120 Heidelberg, Germany
33
Department of Bioscience at Novum, Karolinska Institutet
Stockholm, SE 141 57, Sweden
Search for other works by this author on:
,
33
Department of Bioscience at Novum, Karolinska Institutet
Stockholm, SE 141 57, Sweden
Search for other works by this author on:
,
11
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet
Stockholm, SE 171 77, Sweden
44
Unit of Esophageal and Gastric Research, Department of Molecular Medicine and Surgery, Karolinska Institutet
Stockholm, SE 171 76, Sweden
Search for other works by this author on:
,
22
Division of Molecular Genetic Epidemiology, German Cancer Research Center
69120 Heidelberg, Germany
33
Department of Bioscience at Novum, Karolinska Institutet
Stockholm, SE 141 57, Sweden
Search for other works by this author on:
11
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet
Stockholm, SE 171 77, Sweden
Search for other works by this author on:
Received:
14 October 2005
Revision received:
08 March 2006
Cite
Weimin Ye, Rajiv Kumar, Gabriela Bacova, Jesper Lagergren, Kari Hemminki, Olof Nyrén, The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case–control study in Sweden , Carcinogenesis, Volume 27, Issue 9, September 2006, Pages 1835–1841, https://doi.org/10.1093/carcin/bgl017
Close
Navbar Search Filter Mobile Enter search term Search
Abstract
Mechanisms behind the strong associations of esophageal adenocarcinoma risk with gastroesophageal reflux (GOR) and body mass remain to be defined. In a nationwide population-based case–control study, we examined associations of polymorphisms in the DNA repair genes XPD, XPC, XRCC1 and XRCC3 with risk of esophageal adenocarcinoma, squamous-cell carcinoma (SCC) and gastric cardia adenocarcinoma, and paid special attention to possible interactions with symptomatic reflux or body mass. We collected blood samples from 96, 81 and 126 interviewed incident cases of esophageal adenocarcinoma, esophageal SCC and gastric cardia adenocarcinoma, respectively, and 472 randomly selected controls, frequency-matched with regard to age and sex. DNA was extracted and polymorphisms in XPD codon 751 (Lys→Gln), codon 312 (Asp→Asn), C insertion in intron 10 of XPD, XPC codon 939 (Lys→Gln), XRCC1 codon 399 (Arg→Gln) and XRCC3 codon 241 (Thr→Met) were examined using PCR–RFLP. Odds ratios (ORs) derived from multivariate logistic regression with adjustments for potential confounding factors estimated relative risks. XPD codon 751 Lys/Gln and Gln/Gln genotypes, compared with Lys/Lys genotype, were both associated with a more than doubled risk for esophageal adenocarcinoma (OR = 2.4; 95% CI = 1.4–4.4; OR = 2.7, 95% CI = 1.3–5.9). The combined effects of these genotypes and symptomatic GOR or body mass showed borderline significant deviation from additivity. Excess risks for esophageal SCC were also noted for XPD 751Gln variant genotypes. Other studied variants were not found to be related to the three tumors. Our study suggests that XPD 751Gln allele is a potential genetic marker for susceptibility to esophageal adenocarcinoma.
© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Topic:
- alleles
- polymerase chain reaction
- polymorphism
- squamous cell carcinoma
- esophageal adenocarcinoma
- gastroesophageal reflux disease
- codon nucleotides
- dna
- genotype
- introns
- lysine
- restriction fragment length polymorphism
- genetic markers
- glutamine
- neoplasms
- squamous cell carcinoma, esophageal
- dna repair gene
- gastric cardia adenocarcinoma
- ercc2 gene
- xrcc1 gene
You do not currently have access to this article.
Personal account
- Sign in with email/username & password
- Get email alerts
- Save searches
- Purchase content
- Activate your purchase/trial code
- Add your ORCID iD
Get help with access
Institutional access
Access to content on Oxford Academic is often provided through institutional subscriptions and purchases. If you are a member of an institution with an active account, you may be able to access content in one of the following ways:
IP based access
Typically, access is provided across an institutional network to a range of IP addresses. This authentication occurs automatically, and it is not possible to sign out of an IP authenticated account.
Sign in through your institution
Choose this option to get remote access when outside your institution. Shibboleth/Open Athens technology is used to provide single sign-on between your institution’s website and Oxford Academic.
- Click Sign in through your institution.
- Select your institution from the list provided, which will take you to your institution's website to sign in.
- When on the institution site, please use the credentials provided by your institution. Do not use an Oxford Academic personal account.
- Following successful sign in, you will be returned to Oxford Academic.
If your institution is not listed or you cannot sign in to your institution’s website, please contact your librarian or administrator.
Sign in with a library card
Enter your library card number to sign in. If you cannot sign in, please contact your librarian.
Society Members
Society member access to a journal is achieved in one of the following ways:
Sign in through society site
Many societies offer single sign-on between the society website and Oxford Academic. If you see ‘Sign in through society site’ in the sign in pane within a journal:
- Click Sign in through society site.
- When on the society site, please use the credentials provided by that society. Do not use an Oxford Academic personal account.
- Following successful sign in, you will be returned to Oxford Academic.
If you do not have a society account or have forgotten your username or password, please contact your society.
Sign in using a personal account
Some societies use Oxford Academic personal accounts to provide access to their members. See below.
Personal account
A personal account can be used to get email alerts, save searches, purchase content, and activate subscriptions.
Some societies use Oxford Academic personal accounts to provide access to their members.
Viewing your signed in accounts
Click the account icon in the top right to:
- View your signed in personal account and access account management features.
- View the institutional accounts that are providing access.
Signed in but can't access content
Oxford Academic is home to a wide variety of products. The institutional subscription may not cover the content that you are trying to access. If you believe you should have access to that content, please contact your librarian.
Institutional account management
For librarians and administrators, your personal account also provides access to institutional account management. Here you will find options to view and activate subscriptions, manage institutional settings and access options, access usage statistics, and more.
Purchase
Short-term Access
To purchase short-term access, please sign in to your personal account above.
Don't already have a personal account? Register
The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case–control study in Sweden - 24 Hours access
EUR €51.00
GBP £44.00
USD $55.00
Rental
This article is also available for rental through DeepDyve.
Citations
Views
Altmetric
Metrics
Total Views 920
649 Pageviews
271 PDF Downloads
Since 12/1/2016
Month: | Total Views: |
---|---|
December 2016 | 1 |
January 2017 | 2 |
February 2017 | 2 |
July 2017 | 1 |
September 2017 | 4 |
October 2017 | 2 |
November 2017 | 3 |
December 2017 | 15 |
January 2018 | 8 |
February 2018 | 6 |
March 2018 | 13 |
April 2018 | 3 |
May 2018 | 6 |
June 2018 | 8 |
July 2018 | 13 |
August 2018 | 43 |
September 2018 | 4 |
October 2018 | 9 |
November 2018 | 12 |
December 2018 | 5 |
January 2019 | 8 |
February 2019 | 25 |
March 2019 | 15 |
April 2019 | 17 |
May 2019 | 17 |
June 2019 | 13 |
July 2019 | 14 |
August 2019 | 10 |
September 2019 | 14 |
October 2019 | 8 |
November 2019 | 12 |
December 2019 | 7 |
January 2020 | 6 |
February 2020 | 20 |
March 2020 | 10 |
April 2020 | 202 |
May 2020 | 13 |
June 2020 | 15 |
July 2020 | 4 |
August 2020 | 9 |
September 2020 | 5 |
October 2020 | 8 |
November 2020 | 13 |
December 2020 | 9 |
January 2021 | 3 |
February 2021 | 6 |
March 2021 | 6 |
April 2021 | 6 |
May 2021 | 5 |
June 2021 | 7 |
July 2021 | 2 |
August 2021 | 5 |
September 2021 | 11 |
October 2021 | 4 |
November 2021 | 4 |
December 2021 | 1 |
January 2022 | 8 |
February 2022 | 2 |
March 2022 | 4 |
April 2022 | 4 |
May 2022 | 6 |
June 2022 | 5 |
July 2022 | 11 |
August 2022 | 13 |
September 2022 | 12 |
October 2022 | 6 |
November 2022 | 9 |
December 2022 | 7 |
January 2023 | 4 |
February 2023 | 4 |
March 2023 | 8 |
April 2023 | 3 |
May 2023 | 4 |
June 2023 | 4 |
July 2023 | 4 |
August 2023 | 10 |
September 2023 | 6 |
October 2023 | 4 |
November 2023 | 7 |
December 2023 | 4 |
January 2024 | 4 |
February 2024 | 23 |
March 2024 | 4 |
April 2024 | 6 |
May 2024 | 6 |
June 2024 | 3 |
July 2024 | 14 |
August 2024 | 6 |
September 2024 | 7 |
October 2024 | 4 |
Citations
67 Web of Science
×
Email alerts
Citing articles via
More from Oxford Academic